Iron-derived reactive oxygen species (ROS) are implicated in the pathogenesis of numerous vascular disorders including atherosclerosis, microangiopathic haemolytic anaemia, vasculitis and reperfusion injury. One abundant source of redox-active iron is haem, which is inherently dangerous when released from intracellular haem proteins. The present review concerns the likely involvement of haem in vascular endothelial cell damage and the strategies used by endothelium to minimize such damage. Exposure of endothelial cells to haem greatly potentiates cell killing mediated by polymorphonuclear leukocytes and other sources of ROS. Free haem also promotes the conversion of low-density lipoprotein to cytotoxic oxidized products. If only because of its abundance, haemoglobin probably represents the most important potential source of haem within the vascular endothelium; free haemoglobin in plasma, when oxidized, can transfer haem to endothelium, thereby enhancing cellular susceptibility to oxidant-mediated injury. As a defence against such toxicity, upon exposure to free haem, endothelial cells up-regulate haem oxygenase-1 and ferritin. Haem oxygenase is a haem-degrading enzyme that opens the porphyrin ring, producing biliverdin, carbon monoxide and a most dangerous product-free redox-active iron. The latter can be controlled effectively by sequestration within ferritin, a multimeric protein with a very high capacity for storing iron. These homeostatic adjustments have been shown to be effective in the protection of endothelium against the damaging effects of exogenous haem and oxidants. The central importance of this protective system was highlighted recently by the discovery of a child diagnosed with haem oxygenase-1 deficiency, who exhibited extensive endothelial damage.
Introduction
Haem is a crucial substance which is absolutely required for aerobic life. However, free haem can be quite cytotoxic, particularly in the presence of oxidants or activated phagocytes. Of all sites in the body, the vasculature-and in particular the endothelial lining-may be at greatest risk of exposure to free haem. This is because erythrocytes contain haem at a concentration of 20 mmol/l and are vulnerable to unexpected lysis. The extracellular haemoglobin is easily oxidized, to methaemoglobin, which, in turn, will readily release haem. Given the hydrophobic nature of haem, it is no surprise that it easily crosses cell membranes and can synergistically enhance cellular oxidant damage. Here, we present a brief review of the nature of haem-mediated cytotoxicity and of the strategies by which normal endothelium manages to protect itself from this clear and present danger.
Direct haem toxicity to vascular endothelial cells
Damage caused by reactive oxygen species (ROS) can be greatly amplified by 'free' redox-active iron [1] . For example, iron-rich Staphylococcus aureus are three orders of magnitude more susceptible to killing by hydrogen peroxide than are iron-poor staphylococci [2] . Conversely, depletion of cellular iron powerfully protects eukaryotic and prokaryotic cells against oxidant challenge [3] . One abundant source of potentially toxic iron is haem.
Haem, a ubiquitous iron-containing compound, is present in large amounts in many cells and is also inherently dangerous, particularly when it escapes from intracellular sites. Haem greatly amplifies cellular damage arising from activated oxygen [4, 5] . The toxicity of free haem derives from the ease with which this highly hydrophobic compound can enter and cross cell membranes. Both in vitro and in vivo, cells will accumulate exogenous haem and synergistically amplify the cytotoxic effects of oxidants of reagent, enzymatic or cellular origin. Haem uptake by endothelial cells can exacerbate their damage by polymorphonuclear leukocytes (PMNs)-cells that tend to marginate along endothelial surfaces in the presence of diverse inflammatory mediators.
The uptake of haem is required for this synergistic toxicity, and the hydrophobicity of haem is critical for entry of haem into cells. The spontaneous uptake of haem and the associated amplification of cellular oxidant sensitivity are both blocked by haemopexin. Haemopexin is certainly not the sole factor in plasma that protects against haem-amplified oxidant damage to endothelium. The initial release of haem from free haemoglobin is blocked by complexation with the haemoglobin-binding protein, haptoglobin. Furthermore, albumin may also limit the intrusion of extracellular haem and its pro-oxidant effects. Once within the cell, haem can promote oxidative damage either directly or, perhaps more importantly, via the release of iron which can occur either through non-enzymatic oxidative degradation of haem or enzymatic, haem oxygenase-catalysed haem cleavage. In either case, the iron initially may lodge within the hydrophobic interstices of the phospholipid bilayer; within this highly oxidizable matrix, iron acts as an especially active catalyst of oxidation of cell membrane constituents [4, 5] .
Although free haem is rapidly incorporated into hydrophobic domains of cells and serves as a source of highly damaging iron [4, 5] , the question remains as to whether intact haemoglobin might also transfer haem to vascular endothelium. Whereas reduced (ferro-or oxy-) haemoglobin is relatively innocuous to endothelial cells, oxidized (ferri-or met-) haemoglobin greatly amplifies oxidant-mediated endothelial injury [9] . This is because methaemoglobin readily releases its haem moieties, as first demonstrated by Bunn and Jandl [10] . At higher concentrations of free methaemoglobin (such as might occur in certain haemolytic diseases and malaria infections), the normal mechanisms for control of free haemoglobin (haptoglobin/haemopexin) will be overwhelmed, and released haem will enter the endothelial cells. The importance of haem release is emphasized by the fact that neither ferrohaemoglobin nor other haem proteins, such as metmyoglobin and cytochrome c, none of which will readily release haem, potentiates endothelial damage by oxidants.
Indirect haem toxicity to endothelial cells: LDL oxidation
Haem can also threaten vascular endothelial cell integrity indirectly by its ability to mediate the oxidative modification of low-density lipoprotein (LDL) [5] [6] [7] [8] . The process of haem-mediated LDL oxidation involves coupled oxidative interactions between LDL, haem, oxidants and antioxidants [5, 6] . The initial step of these complex reactions is the spontaneous insertion of haem into LDL particles. The inserted haem directly promotes extensive oxidative modification of LDL; such modification can be amplified by trace amounts of hydrogen peroxide, PMN-derived oxidants or preformed lipid hydroperoxides within the LDL. Depletion of -tocopherol in LDL is followed by the formation of conjugated dienes, lipid hydroperoxides and thiobarbituric acid-reactive substances.
Haem will oxidatively modify both the lipid moiety of LDL and the apoprotein, the latter of which can be detected through increased anodal electrophoretic mobility. This increased mobility suggests a loss of net positive charge, which can also be assayed independently by measurement of free amino groups on the LDL particles. Fluorescamine-titratable free amino groups of apolipoprotein B-100 progressively decrease during exposure of LDL to haem. During these oxidative reactions between haem, LDL and peroxides, the haem ring (protoporphyrin IX) is degraded, with the resultant release of free iron. Both the destruction of the porphyrin ring and the release of ferrozine-trappable free iron evidently are involved in LDL oxidation. The oxidative scission of the porphyrin ring, presumably via reaction with lipid hydroperoxides, can be detected spectrophotometrically by the decrease in haem absorption at 405 nm ( Figure 1, closed circles) . The subsequent release of Fig. 1 . Haem-catalysed oxidation of low-density lipoprotein. Native LDL (200 mg/ml protein) was exposed to haem (5 mmol/l), and during oxidation of LDL the degradation of the porphyrin ring (protoporphyrin IX) was detected spectrophotometrically at 405 nm (closed circles). The oxidative modification of LDL and the degradation of haem were attenuated by desferrioxamine (open circles). Haemopexin, in stoichiometric amounts with haem, prevented oxidative modification of LDL and scission of the porphyrin ring (closed diamonds).
free iron results in iron catalysis of oxidation of further haem, fatty acids, cholesterol and apolipoprotein B-100 in LDL particles. The importance of this degradation is emphasized by the fact that conjugated diene formation occurs in parallel with the release of iron. The released iron-driven component in haem-mediated LDL oxidation is critical since desferrioxamine attenuates both the oxidative modification of LDL and the degradation of haem (Figure 1,  open circles) .
The requirement for intimate association between LDL and haem in LDL oxidation is supported by experiments employing haemopexin. This serum protein, present at a remarkably high plasma concentration (1 g/l), binds haem with extraordinary avidity and will prevent insertion of haem into LDL. Not surprisingly, haemopexin, in stoichiometric amounts with haem, inhibits oxidative modification of LDL (Figure 1, closed diamonds) . As would also be expected, given the exceptional affinity of haemopexin for haem, other proteins such as haptoglobin and albumin at equimolar concentration do not protect LDL from haem-catalysed oxidation. Potentially relevant to in vivo vascular damage are studies demonstrating that activated PMNs potentiate oxidation of LDL catalysed by haem iron. That such haem-induced LDL oxidation may be involved in vascular damage is supported by the finding that LDL oxidized by haem is extremely cytotoxic to endothelial cells [5, 6] .
Haemoglobin-derived haem and LDL oxidation
Although a number of haem proteins-such as haemoglobin [11] [12] [13] , myoglobin [14] , horseradish peroxidase [15] and myeloperoxidase [16] -have been reported to act as oxidants of LDL, the mechanisms involved are by no means clear. In a plasma-free model, haemoglobin reacting with hydrogen peroxide was shown to induce lipid peroxidation of LDL accompanied by oxidative cross-linking of apolipoprotein B-100 via the formation of ferryl haemoglobin and the subsequent generation of radicals on the globin surface [13] . The authors of that study concluded that negligible haem transfer from haemoglobin to LDL, or none at all, occurred under the oxidative conditions they employed. Oxidation of haemoglobin to the ferryl state by peroxides has been reported to be accompanied by tyrosyl radical formation [17, 18] . In end-stage renal failure patients on chronic haemodialysis therapy, a high degree of apolipoprotein B-100 modification resulted from covalent association of haemoglobin with LDL [19] . Although ferrohaemoglobin in plasma does not itself provoke oxidation of LDL, haemoglobin can be oxidized readily to haem-releasing methaemoglobin in the presence of inflammatory cell-derived oxidants [9, 11] . Accordingly, if endothelial cells are exposed to LDL from plasma containing ferrohaemoglobin and activated PMNs, oxidative endothelial damage develops. Similar cytotoxicity is provoked if cells are exposed to LDL isolated from plasma pre-incubated with either haem or methaemoglobin [11] .
The release of free haem from methaemoglobin is an important precedent event in generating toxic LDL. Once haem is lodged within the LDL, spontaneous oxidative reactions involving small amounts of lipid hydroperoxides or other oxidizing equivalent will lead to oxidative lysis of the haem group and release of haem iron within the LDL particle. Most probably, it is the haemoglobin-derived haem iron that catalyses the further breakdown of haem as well as the oxidation of polyunsaturated fatty acids and other components of LDL.
These studies may have relevance to pathological conditions wherein extracellular methaemoglobin, haem and iron are present. These include renal failure, which can occur in instances of acute intravascular haemolysis, as well as the progression of atherosclerosis wherein oxidation of LDL is recognized as one of the early events.
Cytoprotective antioxidant stratagem of endothelium: haem oxygenase and ferritin
The vascular endothelium, because of its continuous contact with circulating red blood cells may be at greatest risk from exogenous haem exposure. If so, endothelial cells might have a strategy to limit the reactivity of haem-derived iron. Indeed, endothelial exposure to haem or methaemoglobin induces sequential synthesis of haem oxygenase-1 followed by ferritin [5, 9, 20, 21] . The induction of haem oxygenase-1 and ferritin genes is associated with high resistance to oxidant-mediated injury and to the accumulation of endothelial oxidation products [5, 9, 20] .
Haem oxygenase is a haem-degrading enzyme that opens the porphyrin ring, producing biliverdin, carbon monoxide and free iron [22, 23] . Biliverdin reductase catalysis converts biliverdin to bilirubin. Three genes encode three isoenzymes of haem oxygenase. Haem oxygenase-1, identified as a 32.8 kDa stress protein [24] , is transcriptionally inducible by a variety of agents, such as haem, oxidants and cytokines [25, 26] . Haem oxygenase-2 is constitutively active as a metabolizer of haem. The function of haem oxygenase-3 is still under investigation in rodents [27] , but it is not present in human cells.
Ferritin, a multimeric protein with a very high capacity for storing iron (4500 mol of iron/mol of ferritin), consists of 24 subunits of two types (heavy chain and light chain) [28] . In the ferritin shell, the proportion of heavy and light subunits depends on the iron status of the cell or tissue and varies between organs and species. The heavy chain of ferritin manifests ferroxidase activity that catalyses the oxidation of ferrous iron under aerobic conditions to ferric iron to allow intracellular iron storage in biological systems. The iron-mediated regulation of ferritin synthesis occurs primarily by posttranscriptional/translational modulation.
By increasing the expression of haem oxygenase-1 and ferritin, endothelial cells can survive lethal oxidative stress derived either from activated inflammatory cells [20] , oxidized LDL [29] or other oxidants [5, 9, 20, 30] . The salutary effects of enhanced haem oxygenase enzyme activity are not intuitively obvious. Although catabolism of haem may rid the cell of a membrane-permeant form of iron, the resultant non-haem iron would represent a potential hazard unless sequestered by ferritin. The unique molecular characteristics of ferritin-high sequestering capacity for inorganic iron and ferroxidase activity of the heavy chain-prevent the accumulation of cellular Fe 2þ , the ultimate catalyst of haem-mediated oxidative damage. Induction of the synthesis of ferritin, an intracellular protein present in species ranging from bacteria to humans, is an important mechanism for the control of reactive iron and consequent suppression of oxidant damage [20] . Conversion of haem by haem oxygenase to biliverdin and bilirubin was demonstrated to protect neurons against oxidative damage [31, 32] . Although bilirubin itself may be an important antioxidant [33] , endothelial cells lack biliverdin reductase activity. Therefore, any protection of endothelial cells associated with haem oxygenase activity probably does not involve bilirubin formation. In addition to bilirubin, the carbon monoxide produced during the degradation of haem has attracted a great deal of interest as a potential regulator of vascular tone and haemostasis, as well as limiting proinflammatory processes [34] [35] [36] [37] .
Haem is not the only trigger of haem oxygenase and ferritin synthesis. Endothelial cells exposed to oxidized LDL (sublethal concentrations) also increase the expression of haem oxygenase-1 as well as ferritin [5, 11, 38] . This induction probably involves LDL-associated lipid hydroperoxides or secondary oxidation events caused by peroxides and iron. Enzymatic reduction of lipid hydroperoxides within oxidized LDL or depletion of cellular iron in endothelium prevents the induction of both haem oxygenase-1 and ferritin.
Haem oxygenase-1 deficiency
The toxic effects of haem may be important in a number of pathologies [39] [40] [41] [42] . These include not only acute conditions such as intravascular haemolysis, which can lead to renal failure, but also more insidious processes such as atherogenesis in which intralesional deposits of iron perhaps derived from erythrocytes have been observed [43] . Intriguingly, up-regulation of haem oxygenase and ferritin genes in endothelium occurs in the early phase of progression of atherosclerotic lesions [29, 44] , possibly reflecting cellular response to haem-or iron-generated lipid peroxidation products.
The central importance of haem oxygenase-1 in vascular biology was highlighted by the discovery of a child with haem oxygenase-1 deficiency [45, 46] . In this haem oxygenase-1-deficient child, both intravascular haemolysis and endothelial cell injury were prominent features. Mesangioproliferative glomerular changes in the kidney as well as fatty streaks and fibrous plaques in the aorta were also revealed. Similar damage to endothelium, as well as hepatic and renal tubular cytotoxicity, has been observed in transgenic knockout mice deficient in haem oxygenase-1 [47] . Importantly, oxidation of haemoglobin to methaemoglobin occurred in the child's plasma, and iron was accumulating in his LDL [11] . Several independent assays for LDL oxidation suggested that oxidative modification of lipoprotein was taking place in the haem oxygenase-1-deficient child's plasma [11] . Products of reactions between haem/ haem iron and LDL are distinctly cytotoxic and could well account for some, perhaps most, of the endothelial damage observed in this condition. Methaemoglobin represents a hazard to vascular endothelial cells by not only catalysing the oxidation of LDL but also sensitizing endothelium to oxidant damage. It is tempting to speculate that endothelial cells of the haem oxygenase-1-deficient child were prone to oxidative damage arising from both haem-mediated oxidation of LDL and, perhaps, an associated lack of adaptive response (i.e. induction of haem oxygenase-1 and ferritin synthesis).
